Bpn14770
Payments companies reported to CMS as associated with Bpn14770. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bpn14770, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bpn14770
These are the largest totals companies reported as associated with Bpn14770. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Arthur Jeng | Sylmar, CA | Infectious Disease | $10,620.00 |
| James Freston | Farmington, CT | Gastroenterology (Internal Medicine) | $2,632.50 |
| Michael Tranfaglia | Newburyport, MA | Psychiatry | $2,580.00 |
| Lauren Meyers | Chicago, IL | Pediatrics (Nurse Practitioner) | $1,950.00 |
| Victoria Wilkins | Salt Lake City, UT | Hospitalist | $1,334.46 |
| Sailaja Golla | Orange, CA | Neurology With Special Qualifications In Child Neurology | $1,318.54 |
| Randi Hagerman | Davis, CA | Developmental - Behavioral Pediatrics | $1,288.50 |
| Gary Feldman | Irvine, CA | Sleep Medicine (Family Medicine) | $1,271.51 |
| Deborah Barbouth | Miami, FL | Clinical Genetics (M.D.) | $1,176.30 |
| Dejan Budimirovic | Baltimore, MD | Child & Adolescent Psychiatry | $1,112.58 |
Prescribed Bpn14770?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.